| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.031 | 0.6 |